Isoproterenol blockade in man; comparison between penbutalol and acebutolol.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000328:Adult; D000813:Anilides / Q000494:pharmacology; D001249:Asthma / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002082:Butylamines / Q000494:pharmacology; D002302:Cardiac Output / Q000187:drug effects; D002496:Central Venous Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D003517:Cyclopentanes / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004983:Ethanolamines / Q000494:pharmacology* / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D008297:Male; D010647:Phenyl Ethers / Q000494:pharmacology; D010919:Placebos; D011412:Propanolamines / Q000494:pharmacology* / Q000627:therapeutic use; D011437:Propylamines / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000813:Anilides; D002082:Butylamines; D003517:Cyclopentanes; D004983:Ethanolamines; D010647:Phenyl Ethers; D010919:Placebos; D011412:Propanolamines; D011437:Propylamines; D007545:Isoproterenol